Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

HPIM Onco > 109 : Upper GI tract Cancers > Flashcards

109 : Upper GI tract Cancers Flashcards

1
Q

T or F: In esophageal cancers worldwide, adenocarcinoma is the more common cell type.

A

False

Squamous cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Some etiologic factors associated with SCCA of esophagus

A
  1. Excess alcohol consumption (whiskey > wine, beer)
  2. Cigarette smoking
  3. Ingested carcinogens
  4. Mucosal damage from physical agents (extremely hot tea long-term exposure, Lye ingestion, radiation-induced strictures)
  5. Esophageal web with glossitis and iron deficiency (Plummer-Vinson or Paterson-Kelly syndrome)
  6. Hyperkeratosis and pitting of the palms and soles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Some etiologic factors associated with ADENOCARCINOMA of esophagus

A
  1. Chronic GERD
  2. Obesity
  3. Barrett’s esophagus
  4. Male sex
  5. Cigarette smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Part of the esophagus where adenocarcinoma arises?

A

Distal third of esophagus

From squamous epithelium –> columnar mucosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

T or F: Adenocarcinoma of esophagus behave clinically like gastric adenocarcinomas, hence they are associated with Helicobacter pylori infections.

A

False

NOT associated with H. pylori

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Percentage of cancer in each part of the esophagus

A

Upper third : 5%
Middle third: 20%
Lower third: 75%

Incidence of adenoCA in esophagus is increasing in the US more than SCCA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

T or F: SCCA and adenoCA of esophagus can be distinguished radiographically or endoscopically

A

False

CANNOT be distinguished

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Percentage of esophageal circumference infiltrated with cancer when difficulty of swallowing begin to appear?

A

> 60%

By the time symptoms appear, disease is already very advanced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Esophageal CA most commonly spreads to what adjacent organs?

A
  1. Adjacent and supraclavicular lymph nodes
  2. Liver
  3. Lungs
  4. Pleura
  5. Bone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Procedure that should be performed in ALL patients SUSPECTED of having an esophageal abnormality to visualize and identify the tumor, and also to obtain histopathologic confirmation of diagnosis

A

Esophagoscopy

a. Endoscopic inspection of larynx, trachea, and bronchi should also be carried out
b. Endoscopic examination of fundus of stomach is imperative as well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Imagings used to determine extent of tumor spread to the mediastinum and para-aortic lymph nodes

A

CT scan of chest and abdomen

Endoscopic ultrasound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Imaging that provides useful assessment of the presence of distant metastatic disease with accurate information regarding spread to mediastinal lymph nodes, helpful in defining radiation therapy fields

A

Positron emission tomography (PET) scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prognosis for patients with esophageal carcinoma

A

Poor

5-year survival after diagnosis is 10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Goal of treatment for esophageal CA

A

Symptom control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Surgical resection in esophageal cancer

A

Feasible only in 45% of cases
Associated with frequent residual tumors
Increased post-op mortality due to many complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T or F: Chemotherapy with radiation therapy produces better survival outcome than radiotherapy alone

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Patient presented with esophageal CA, however the tumor is unresectable. What major issues in the management should you be concerned or need to prioritize?

A
  1. Dysphagia (endoscopic dilatation, radiation therapy)
  2. Malnutrition (gastrostomy or jejunostomy)
  3. Tracheoesophageal fistulas (stenting)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

T or F: Gastric cancer is associated among lower socioeconomic class and intake of dietary carcinogens

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Frequencly of the different stomach cancers

A

Adenocarcinoma: 85%
Lymphomas, MALT: <15%
Leiomyosarcoma, GIST : 1-3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

2 types of gastric adenocarcinoma

A
  1. Diffuse type

2. Intestinal type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Type of gastric adenoCA common in younger patients, develops througgout the stomach, causing linitis plastica or “leather bottle” appearance, and carries poorer prognosis

A

Diffuse type

Cell cohesion is absent, and individual cells infiltrate and thicken the stomach wall without forming a discrete mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Type of adenoCA which are frequently ulcerative, more common in the ANTRUM and LESSER curvature of stomach, often initiated by H. pylori infection

A

Intestinal type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Part of the stomach where most gastric CA originate

A

Proximal third of stomach (40%)

30% distal stomach
20% midportion
10% entire stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Factor in the causation of gastric carcinoma due to long-term ingestion of high concentrations of nitrates in dried, smoked, and salted foods

A

Nitrate-converting bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

T or F: Increased gastric acidity is an endogenous factor that favors the growth of nitrate-converting bacteria in stomach

A

False

Decreased gastric acidity
Others: prior antrectomy, atrophic gastritis and/or pernicious anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

T or F: Infection with H. pylori increases risk of gastric cancer by sixfold.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

A germline mutation in this gene, inherited in autosomal dominant pattern, normally codes for a cell adhesion protein, results in high incidence of occult diffuse-type gastric cancers in young asymptomatic carriers

A

E-cadherin gene (CDH1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

T or F: A palpable abdominal mass may be an early sign caused by diffuse type of gastric cancer

A

False

There may be no early physical signs
Palpable mass indicates long-standing growth and predicts regional extension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

How do gastric CA metastasize?

A
  1. Direct extension
  2. Lymphatics
  3. Hematogenous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Gastric CA that metastasize to the ovary

A

Krukenberg’s tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Gastric CA that metastasize to the periumbilical region

A

“Sister Mary Joseph node”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Gastric CA that metastasize to the peritoneal cul-de-sac

A

Blumer’s shelf palpable on rectal or vaginal examination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Most common site for hematogenous spread of tumor in Gastric CA

A

Liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Pertinent history that should mandate a search for an occult blood in the stool

A
  1. Iron-deficiency anemia in MEN

2. Occult blood in stool in both sexes

35
Q

UNUSUAL clinical features associated with gastric adenocarcinomas

A
  1. Migratory thrombophlebitis
  2. Microangiopathic hemolytic anemia
  3. Diffuse seborrheic keratoses (Leser-Trelat sign)
  4. Acanthosis nigricans
36
Q

Treatment for Gastric Adenocarcinoma

A

Complete surgical removal of tumor WITH resection of adjacent lymph nodes

37
Q

Treatment of choice for DISTAL carcinomas of gastric adenocarcinoma

A

Subtotal gastrectomy

38
Q

Treatment of choice for PROXIMAL carcinomas of gastric adenocarcinoma

A

Total or near-total gastrectomy

39
Q

T or F: 5-year survival of gastric adenoCa patients who underwent complete resection is higher for proximal tumors when compared to distal tumors.

A

False

Higher survival in DISTAL tumors (20%) vs proximal (<10%)

40
Q

In gastric CA, best form of palliation and enhance probability of benefit from subsequent therapy

A

Reduction of tumor bulk

41
Q

T or F: Gastric adenocarcinoma is a highly radiosensitive tumor.

A

False

Relatively radioRESISTANT
Requires external-beam irradiation that exceed tolerance of surrounding structures
Major function: palliation of PAIN only

42
Q

Based on clinical setting, this chemodrug for gastric adenoCA functions as radiosensitizer that increases survival of patients in combination with radiation therapy compared to radiotherapy alone

A

5-fluorouracil (5-FU)

43
Q

Drug combination for advanced gastric adenocarcinoma that gives partial response in 30-50% of cases

A

Cisplatin + Epirubicin or Docetaxel with

5-FU infusion OR Capecitabine OR Irinotecan

44
Q

Which therapy reduces recurrence rate and increases survival in gastric CA?

A. adjuvant chemotherapy alone + complete resection of gastric cancer
B. Combination chemotherapy before and after surgery (perioperative treatment)
C. Postoperative chemotherapy with radiation therapy

A

B and C

45
Q

Organ which is the most frequent extranodal site for lymphoma

A

Stomach

46
Q

Characteristics of gastric lymphoma

A
  1. Difficult to distinguish clinically from gastric adenoCA
  2. Detected during sixth decade of life
  3. Presents with epigastric pain, early satiety, and generalized fatigue
  4. Characterized by ulcerations with a ragged, thickened mucosal pattern seen on contrast radiographs of endoscopic appearance
47
Q

T or F: H. pylori increases risk for gastric lymphoma in general and in mucosa-associated lymphoid tissue (MALT) lymphomas

A

True

48
Q

T or F: Antibiotic treatment to eradicate H. pylori infection can regress gastric MALT lymphomas.

A

True

> 75% of gastric MALT lymphomas regress after treatment
Should be considered before surgery, radiation or chemotherapy
But still needs to undergo periodic endoscopic surveillance

49
Q

Highly effective chemotherapy regimen for gastric lymphoma

A

CHOP protocol (cyclophosphamide + doxorubicin + vincristine + prednisone) PLUS rituximab

50
Q

Part of the stomach frequently involved in leiomyosarcomas and GISTs

A

Anterior and posterior wall of the gastric fundus

51
Q

T or F: Leiomyosarcoma and GISTs rarely invade adjacent viscera and characteristically do not metastasize to lymph nodes

A

True

52
Q

Adjacent organs where leiomyosarcoma and GIST can spread

A
  1. Liver

2. Lungs

53
Q

Treatment of choice for gastric (nonlymphoid) sarcoma

A

Surgical resection

Combination chemotherapy : for metastatic disease

54
Q

All gastric sarcoma tumors should be analyzed for what mutation?

A

c-kit receptor

55
Q

GISTs are unresponsive to conventional chemotherapy. However, this selective inhibitor of c-kit tyrosine kinase are given to patients with GIST because it can prolong their survival in 50% of cases

A

Imatinib mesylate (Gleevec) 400-800mg PO daily

56
Q

Situations where small-bowel tumors should be considered

A
  1. Recurrent, unexplained episodes of crampy abdominal pain
  2. Intermittent bouts of intestinal obstruction, especially in the absence of inflammatory bowel disease (IBD) or prior abdominal surgery
  3. Intussusception in the adult
  4. Evidence of chronic intestinal bleeding in the presence of negative conventional and endoscopic examination
57
Q

Diagnostics for small-bowel tumors

A
  1. Small-bowel barium study / infusing barium thru NGT placed into duodenum (enteroclysis)
  2. Capsule endoscopic procedures
58
Q

Benign tumors of the small-bowel is more often seen in the proximal or distal part?

A

Distal small intestine

59
Q

Most common benign tumors of small-bowel

A
  1. Adenomas
  2. Leiomyomas
  3. Lipomas
  4. Angiomas
60
Q

Benign tumor of the small-bowel that represent hypertrophy or hyperplasia of submucosal duodenal glands secreting a highly viscous alkaline mucus

A

Brunner’s gland adenomas

61
Q

Benign tumor of the small-bowel that are occasionally located outside the pancreas

A

Islet cell adenomas

62
Q

Are papillary villous adenomas benign or malignant tumors?

A

Benign

63
Q

T or F: Hamartomas (juvenile polyps) in Peutz-Jeghers syndrome have low potential for malignant degeneration

A

True

64
Q

Benign tumors of the small intestine that occur in greatest frequency in the distal ileum and ileocecal valve that is radiolucent on imaging, usually intramural and asymptomatic.

A

Lipomas

65
Q

T or F: Multiple intestinal telangiectasias occur in nonhereditary form confined to the GI tract or as part of the hereditary Osler-Rendu-Weber syndrome. These are commonly benign lesions.

A

True

66
Q

Best procedure to evaluate angiomas especially during bleeding

A

Angiography

67
Q

Small-bowel malignancies are rare, however, what type of patients do they commonly occur?

A
  1. Long-standing regional enteritis
  2. Celiac sprue
  3. AIDS
68
Q

Most frequently occurring small-bowel malignancies

A
  1. Ampullary carcinomas ( fr biliary or pancreatic ducts)
  2. Adenocarcinomas
  3. Lymphomas
  4. Carcinoid tumors
  5. Leiomyosarcomas
69
Q

Most common primary cancers of the small bowel accounting for 50% of malignant tumors

A

Adenocarcinomas

70
Q

Sites where most of the adenocarcinoma of small bowel frequently occur

A

Distal duodenum

Proximal jejunum

71
Q

Diagnosis for adenocarcinoma of small-bowel

A

Endoscopy

Biopsy under direct vision

72
Q

Treatment of choice for adenocarcinomas of small-bowel

A

Surgical resection with suggested postoperative adjuvant chemotherapy

73
Q

Type of intestinal lymphoma requiring histologic confirmation where palpable adenopathy and hepatosplenomegaly are absent and no evidence of lymphoma is seen on imaging studies

A

PRIMARY intestinal lymphoma

> non-Hodgkin’s lymphomas (T cell origin)

74
Q

Type of intestinal lymphoma consisting of involvement of intestine by a lymphoid malignancy extending from involved retroperitoneal or mesenteric lymph nodes

A

SECONDARY intestinal lymphoma

75
Q

Most frequent site of occurrence of intestinal lymphoma

A

Ileum (most frequent) - highest amt of lymphoid cells
Jejunum
Duodenum (least frequent)

76
Q

Risk of small-bowel lymphoma is increased in these conditions

A
  1. Prior history of malabsorptive conditions (celiac sprue)
  2. Regional enteritis
  3. Depressed immune function (congenital immunodeficiency syndromes, prior organ transplantation, autoimmune disorders, AIDS)
77
Q

Imaging findings where small-bowel lymphoma can be suspected

A
  1. Infiltration and thickening of mucosal folds
  2. Mucosal nodules
  3. Areas of irregular ulceration
  4. Stasis of contrast material
78
Q

Confirmation of small-bowel lymphoma

A

Surgical exploration and resection of invovled segments

79
Q

Initial treatment modality for small-bowel lymphoma

A

Resection of tumor

80
Q

A B-cell tumor, which is a unique form of small-bowel lymphoma diffusely involving the entire intestine; presentation includes chronic diarrhea and steatorrhea associated with vomiting and abdominal cramps

A

Immunoproliferative small intestine disease (IPSID) OR
Mediterranean lymphoma OR
Alpha heavy chain disease

81
Q

Curious feature of this disease is presence of blood and intestinal secretions of an abnormal IgA that contains a shortened alpha heavy chain devoid of light chains

A

IPSID

82
Q

Treatment for IPSID

A

Combination of antibiotics (Tetracycline) and chemotherapy

83
Q

Tumors that arise from argentaffin cells of the crypts of Lieberkuhn and are found from the distal duodenum to the ascending colon

A

Carcinoid tumors

HPIM Onco (4 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions